Related references
Note: Only part of the references are listed.Randomized Controlled Trial of Mycophenolate Mofetil in Children, Adolescents, and Adults With IgA Nephropathy
Ronald J. Hogg et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy
Thomas Knoop et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Predictors of outcome for severe IgA nephropathy in a multi-ethnic US cohort
Ana Huerta Arroyo et al.
CLINICAL NEPHROLOGY (2015)
Novel genes and variants associated with IgA nephropathy by co-segregating with the disease phenotypes in 10 IgAN families
Ruihong Liu et al.
GENE (2015)
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
Vladimir Tesar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Current Understanding of the Role of Complement in IgA Nephropathy
Nicolas Maillard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
Laureline Berthelot et al.
KIDNEY INTERNATIONAL (2015)
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy
Grazia Serino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
Thomas Rauen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Identification of new susceptibility loci for IgA nephropathy in Han Chinese
Ming Li et al.
NATURE COMMUNICATIONS (2015)
Long-Term Outcome of IgA Nephropathy Patients with Recurrent Macroscopic Hematuria
WeiBo Le et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Polymorphism of DEFA in Chinese Han population with IgA nephropathy
Ricong Xu et al.
HUMAN GENETICS (2014)
Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone
Xiaowei Liu et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Cytokines Alter IgA1 O- Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*
Hitoshi Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The genetics and immunobiology of IgA nephropathy
Krzysztof Kiryluk et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2014)
The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation
Emily P. McQuarrie et al.
KIDNEY INTERNATIONAL (2014)
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
Krzysztof Kiryluk et al.
NATURE GENETICS (2014)
MicroRNAs in IgA nephropathy
Cheuk-Chun Szeto et al.
NATURE REVIEWS NEPHROLOGY (2014)
Pathology of IgA nephropathy
Ian S. D. Roberts
NATURE REVIEWS NEPHROLOGY (2014)
Clinical implication of crescentic lesions in immunoglobulin A nephropathy
Mi Jung Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
Tetsuya Kawamura et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
Takahito Moriyama et al.
PLOS ONE (2014)
Long-term prognosis of clinically early lgA nephropathy is not always favorable
Hajeong Lee et al.
BMC NEPHROLOGY (2014)
Pathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
Krzysztof Kiryluk et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management
Byoung-Soo Cho et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up
Gen-yang Cheng et al.
CLINICAL NEPHROLOGY (2013)
Prediction of Outcomes in Crescentic IgA Nephropathy in a Multicenter Cohort Study
Jicheng Lv et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease
Sean J. Barbour et al.
KIDNEY INTERNATIONAL (2013)
Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy
Fumiko Kodama et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study
Cheuk-Chun Szeto et al.
PLOS ONE (2013)
Persistent asymptomatic isolated hematuria in children: clinical and histopathological features and prognosis
Chun-Yue Feng et al.
WORLD JOURNAL OF PEDIATRICS (2013)
Renal Biopsy Findings of Patients Presenting with Isolated Hematuria: Disease Associations
Huanhuan Liu et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
IgA Nephropathy: Molecular Mechanisms of the Disease
Jiri Mestecky et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)
Hitoshi Yokoyama et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters
Hiroshi Kataoka et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy
Rin Asao et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Implementation of proteomic biomarkers: making it work
Harald Mischak et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Laureline Berthelot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients
Min Jeong Kim et al.
JOURNAL OF IMMUNOLOGY (2012)
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression
Dario Roccatello et al.
JOURNAL OF NEPHROLOGY (2012)
Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
Eduardo Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Corticosteroid Therapy in IgA Nephropathy
Jicheng Lv et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy
Grazia Serino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Francois Berthoux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
Yongjun Shi et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient
Jai Radhakrishnan et al.
KIDNEY INTERNATIONAL (2012)
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy
Xue-Qing Yu et al.
NATURE GENETICS (2012)
Pathogenesis of IgA nephropathy
Kar Neng Lai
NATURE REVIEWS NEPHROLOGY (2012)
Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)
Stella Edstrom Halling et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study
Sydney C. W. Tang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
Krzysztof Kiryluk et al.
PLOS GENETICS (2012)
Outcome results in children with IgA nephropathy: a single center experience
Ipek Kaplan Bulut et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2012)
Desmopressin Acetate in Percutaneous Ultrasound-Guided Kidney Biopsy: A Randomized Controlled Trial
Carlo Manno et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Validation Study of Oxford Classification of IgA Nephropathy: The Significance of Extracapillary Proliferation
Ritsuko Katafuchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decades
K.-T. Woo et al.
CLINICAL NEPHROLOGY (2011)
The pathogenesis of IgA nephropathy
Richard J. Glassock
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Francois Berthoux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Pathophysiology of IgA Nephropathy
Hitoshi Suzuki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis
Krzysztof Kiryluk et al.
KIDNEY INTERNATIONAL (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G. Gharavi et al.
NATURE GENETICS (2011)
A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy
You Wang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy
Akira Nishiyama et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
Hilde Kloster Smerud et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effect of Single-Dose Rituximab on Primary Glomerular Diseases
Hidekazu Sugiura et al.
NEPHRON CLINICAL PRACTICE (2011)
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
A. C. ALLEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase
Rajindra P. Aryal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Claudio Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Podocyte number predicts progression of proteinuria in IgA nephropathy
Lan Xu et al.
MODERN PATHOLOGY (2010)
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Sydney C. W. Tang et al.
KIDNEY INTERNATIONAL (2010)
Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
Mai T. Vuong et al.
KIDNEY INTERNATIONAL (2010)
In Crescentic IgA Nephropathy, Fractional Excretion of IgG in Combination with Nephron Loss Is the Best Predictor of Progression and Responsiveness to Immunosuppression
Claudio Bazzi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials
J. Cheng et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Probability, Predictors, and Prognosis of Posttransplantation Glomerulonephritis
Worawon Chailimpamontree et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Macromolecular IgA1 taken from patients with familial IgA Nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro
Ka Ying Tam et al.
KIDNEY INTERNATIONAL (2009)
The ubiquitin-proteasome pathway and IgA nephropathy: a novel link?
Sydney C. W. Tang et al.
KIDNEY INTERNATIONAL (2009)
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
Ian S. D. Roberts et al.
KIDNEY INTERNATIONAL (2009)
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
Daniel C. Cattran et al.
KIDNEY INTERNATIONAL (2009)
Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy
Maria Stangou et al.
NEPHROLOGY (2009)
Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy
Kar Neng Lai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial
Pietro Manuel Ferraro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Application of proteomic analysis to renal disease in the clinic
Bruce A. Julian et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Levels of Urinary Complement Factor H in Patients with IgA Nephropathy are Closely Associated with Disease Activity
J. -J. Zhang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening
Kunihiro Yamagata et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2008)
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy
Ali G. Gharavi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: A long-term follow up of 204 cases in China
Jicheng Lv et al.
NEPHROLOGY (2008)
Is sialylation of IgA the agent provocateur of IgA nephropathy?
Alice Smith et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
The impact of sex in primary glomerulonephritis
Daniel C. Cattran et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
External suppression causes the low expression of the Cosmc gene in IgA nephropathy
Wei Qin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
The glomerular response to IgA deposition in IgA nephropathy
Ivan C. Moura et al.
SEMINARS IN NEPHROLOGY (2008)
Activation of podocytes by mesangial-derived TNF-α:: glomerulo-podocytic communication in IgA nephropathy
Kar Neng Lai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Remission of proteinuria improves prognosis in IgA nephropathy
Heather N. Reich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Kidney disease screening program in japan: History, outcome, and perspectives
Enyu Imai et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z. Moldoveanu et al.
KIDNEY INTERNATIONAL (2007)
Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy
J. M. Myllymaki et al.
KIDNEY INTERNATIONAL (2007)
Genetic heterogeneity in Italian families with IgA nephropathy: Suggestive linkage for two novel IgA nephropathy loci
Luigi Bisceglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: Report from the southwest pediatric nephrology study group
Ronald J. Hogg et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Clinicopathological characteristics and outcome of adult patients with hematuria and/or proteinuria found during routine examination
Peicheng Shen et al.
NEPHRON CLINICAL PRACTICE (2006)
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy:: a double-blind randomized controlled trial
G Frisch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy
LYY Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
S Tang et al.
KIDNEY INTERNATIONAL (2005)
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
J Novak et al.
KIDNEY INTERNATIONAL (2005)
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy
IC Moura et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
D de Zeeuw et al.
KIDNEY INTERNATIONAL (2004)
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy
JA Tumlin et al.
SEMINARS IN NEPHROLOGY (2004)
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
BD Maes et al.
KIDNEY INTERNATIONAL (2004)
Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system
KN Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase
TZ Ju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Podocytopenia and disease severity in IgA nephropathy
KV Lemley et al.
KIDNEY INTERNATIONAL (2002)
Aortic embolism in Claude's syndrome
C Kremer et al.
CEREBROVASCULAR DISEASES (2002)
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy
IC Moura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria
CC Szeto et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Charge-dependent binding of polymeric IgA(1) to human mesangial cells in IgA nephropathy
JCK Leung et al.
KIDNEY INTERNATIONAL (2001)
Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue
T Hishiki et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2001)
Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease):: Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice
P Launay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
P Ruggenenti et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Clinicopathologic study on prognostic markers in IgA nephropathy
J Mera et al.
NEPHRON (2000)
Outcome of IgA nephropathy in adults graded by chronic histological lesions
KF To et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)